- The 8 States Most Likely to Legalize Marijuana Next
- BlackBerry Is Finally Realizing Smartphones Aren't the Answer
- Express Scripts and AbbVie Drug-Pricing Deal Might Devastate Biotech Bull Market
- Dow 18,000: Why This Market Rally May Never Happen Again
- Gilead Sciences Is Not a Buy; It's Heading Lower on Price War: Jim Cramer
Target has been sticking to its agreed-on deal to transact with CME and its own management.
The car insurance provider is buying a majority stake in home insurance provider ARX Holding for $875 million, broadening the insurance company's offerings.
Deal comes as Volcker Rule deadlines near for banks to shed hedge fund and private equity investments.
U.S. M&A jumped 38% in the first 10 months of the year from a year earlier, and is likely to mark the strongest year for deals since 2008 financial crisis.
Investors peering into 2015 should expect to see a rise in mergers and acquisitions among mid-cap companies. Find out why.
Buoyed by favorable equity markets in 2013 going into 2014, strategics showed a strong deal appetite in the first half of 2014, winning a number of big name auctions.
Though the legal software company adds a director to its board, fund still wants to see a sale.
Rick Perna, who got his start at SocGen 17 years ago, joins former NFL player Andrew Kline at the Los Angeles boutique investment bank.
Italian soccer club Bologna Football Club 1909 has found a new majority owner.
Inversion transactions have become a politically controversial topic this year, and the U.S. Treasury Department's Sept. 22 announcement garnered significant attention.